Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis
  • Published Date:
    Jul 17 2017
  • Source:
    AIDS. 31(11):1647-1650.
  • Language:
    English
Filetype[PDF-407.10 KB]


Details:
No Related Documents.
You May Also Like:
  1. Levels of intracellular phosphorylated tenofovir and emtricitabine correlate with natural substrate concentrations in peripheral blood mononuclear cells of persons prescribed daily oral Truvada™ for HIV pre-exposure prophylaxis
    Personal Author:
    Haaland, Richard E.; Holder, Angela; Pau, Chou-Pong; Swaims-Kohlmeier, Alison; Dawson, Carolyn; Smith, Dawn K.; Segolodi, Tebogo M.; Thigpen, Michael C.; Paxton, Lynn A.; Parsons, Teresa L.; Hendrix, Craig W.; Hart, Clyde E.;
    Published Date:
    Jul 01 2017
    Source:
    J Acquir Immune Defic Syndr. 75(3):e86-e88.
    File Type:
    Filetype[PDF - 389.37 KB]
  2. Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 update clinical practice guideline
    Corporate Authors:
    United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Preexposure Prophylaxis Work Group..
    Published Date:
    March 2018
    Description:
    The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure ...
    Status:
    current
    File Type:
    Filetype[PDF - 1.67 MB]
  3. Preexposure prophylaxis for the prevention of HIV infection – 2014 : clinical providers’ supplement
    Personal Author:
    Smith, Dawn K.; Koenig, Linda J.; Martin, Michael; Mansergh, Gordon; Heneine, Walid; Ethridge, Steven F.; Morgan, Marie S.; Mermin, Jonathan; Fenton, Kevin A.;
    Corporate Authors:
    United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.).
    Published Date:
    May 14, 2014
    Description:
    This Clinical Providers’ Supplement is a companion to the 2014 U.S. Public Health Service Clinical Practice Guideline for Preexposure Prophylaxis for the Prevention of HIV Infection. The guideline is intended for use by clinicians in the United Sta...
    Status:
    superseded
    File Type:
    Filetype[PDF - 690.62 KB]
  4. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults
    Personal Author:
    Smith, Dawn K.; Thigpen, Michael C.; Nesheim, Steven R.; Lampe, Margaret A.; Paxton, Lynn A.; Samandari, Taraz; Lansky, Amy; Mermin, Jonathan; Fenton, Kevin A.;
    Corporate Authors:
    Substance Abuse and Mental Health Services Administration (U.S.)
    Published Date:
    Aug 10 2012
    Source:
    MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):586-9.
    Description:
    Morbidity and mortality weekly report. 2012 Aug 10;61(31):586-9.In the United States, an estimated 48,100 new human immunodeficiency virus (HIV) infections occurred in 2009. Of these, 27% were in heterosexual men and women who did not inject drugs, a...
    File Type:
    Filetype[PDF - 96.99 KB]
  5. Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1
    Personal Author:
    Hoenigl, Martin; Jain, Sonia; Moore, David; Collins, Deborah; Sun, Xiaoying; Anderson, Peter L.; Corado, Katya; Blumenthal, Jill S.; Daar, Eric S.; Milam, Joel; Dubé, Michael P.; Morris, Sheldon;
    Corporate Authors:
    for the California Collaborative Treatment Group 595 Team
    Published Date:
    December 2018
    Source:
    Emerg Infect Dis. 24(12):2292-2302
    Description:
    The effectiveness of oral HIV preexposure prophylaxis (PrEP) strongly depends on maintaining adherence. We investigated the association between substance use and PrEP adherence, as well as incident sexually transmitted infections (STIs) in a high-ris...
    File Type:
    Filetype[PDF - 1.35 MB]